QTTB
Q32 Bio Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Q32 Bio Inc.
8.91
pre 8.67 −2.69%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Orbimed AdvisorsOrbimed | $52.6M | 18.40% | +83.22% | |
| 2 | Boxer Capital ManagementBoxer | $40.1M | 14.03% | new | |
| 3 | Atlas Venture Life Science AdvisorsAtlas Venture Life Science | $34.6M | 12.11% | +29.87% | |
| 4 | BVFBVF | $29.9M | 10.47% | new | |
| 5 | RA Capital ManagementRA Capital Management | $29.7M | 10.39% | new | |
| 6 | Point72 Asset ManagementPoint72 | $14.9M | 5.23% | new | |
| 7 | Opaleye ManagementOpaleye | $11.9M | 4.15% | −25.89% | |
| 8 | Logos Global ManagementLogos Global | $10.2M | 3.56% | new | |
| 9 | SummitTX CapitalSummitTX Capital | $9.3M | 3.27% | new | |
| 10 | Ikarian CapitalIkarian Capital | $8.0M | 2.81% | new | |
| 11 | Vanguard Capital ManagementVanguardindex-like | $6.6M | 2.31% | +69.32% | |
| 12 | Woodline PartnersWoodline Partners | $3.6M | 1.28% | new | |
| 13 | American Century CompaniesAmerican Century Companies | $3.5M | 1.22% | +1353.13% | |
| 14 | SanofiSanofi | $3.1M | 1.09% | 0.00% | |
| 15 | Acadian Asset ManagementAcadian | $2.8M | 0.97% | +26.45% | |
| 16 | Acorn Capital AdvisorsAcorn Capital | $2.8M | 0.96% | −31.39% | |
| 17 | Boothbay Fund ManagementBoothbay Fund | $2.4M | 0.85% | new | |
| 18 | Renaissance TechnologiesRenaissance Technologies | $2.3M | 0.80% | −13.20% | |
| 19 | Jane Street GroupJane Street | $2.1M | 0.73% | +148.09% | |
| 20 | Monimus Capital ManagementMonimus | $1.7M | 0.59% | −1.69% | |
| 21 | Geode Capital ManagementGeodeindex-like | $1.6M | 0.55% | +3.84% | |
| 22 | Citadel AdvisorsCitadel | $1.5M | 0.54% | +679.43% | |
| 23 | BlackRockBlackRockindex-like | $1.5M | 0.53% | +37.56% | |
| 24 | Marshall WaceMarshall Wace | $854,153 | 0.30% | +27.85% | |
| 25 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $843,605 | 0.30% | +32.45% |
71 managers report $285.9M of Q32 Bio on form 13F for the quarter ended Jun 30 '26. 9 of them hold 80% of it; Orbimed is largest at 18.40%.
Linked news
No implied move.
No implied move.
Expected move
No implied move.